Cofetuzumab (Anti-PTK7 / CCK4)
Cofetuzumab (Anti-PTK7 / CCK4) (A2803-GRP)
Products
Description
Cofetuzumab (Anti-PTK7 / CCK4) is humanized IgG1 monoclonal antibody against protein tyrosine kinase 7 (PTK7) with potential antitumor activity. MW : 146.7 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2803 |